Literature DB >> 33355277

What about cardiovascular toxicities of immune checkpoint inhibitors?

Raquel Moreno Diaz1, Mario Cazalla Garcia2, Maria Pilar Bautista Sanz2, Rosa Gonzalez Davia3, Adriana Carolina Rosero Rodriguez4.   

Abstract

Entities:  

Keywords:  cardiology; chemotherapy; hospital pharmacy competencies; side effects of drugs; therapeutic drug monitoring

Mesh：

Substances：

Year:  2020        PMID： 33355277      PMCID： PMC7788214          DOI： 10.1136/ejhpharm-2020-002277

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN： 2047-9956


× No keyword cloud information.
  3 in total

Review 1.  Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.

Authors:  Somedeb Ball; Raktim K Ghosh; Sariya Wongsaengsak; Dhrubajyoti Bandyopadhyay; Gopal Chandra Ghosh; Wilbert S Aronow; Gregg C Fonarow; Daniel J Lenihan; Deepak L Bhatt
Journal:  J Am Coll Cardiol       Date:  2019-10-01       Impact factor: 24.094

Review 2.  Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer.

Authors:  Yara van Holstein; Ellen Kapiteijn; Esther Bastiaannet; Frederiek van den Bos; Johanneke Portielje; Nienke A de Glas
Journal:  Drugs Aging       Date:  2019-10       Impact factor: 3.923

Review 3.  Cardiotoxicity of immune checkpoint inhibitors.

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Giancarlo Marone; Gjada Criscuolo; Maria Triassi; Domenico Bonaduce; Gianni Marone; Carlo Gabriele Tocchetti
Journal:  ESMO Open       Date:  2017-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.